PROTEOM
Table of contents:
| Trademark domain | |
| name | is free? |
|---|---|
| proteom.com |  |
The "PROTEOM" trademark, serial number 78178639 , was filed on 25th of October 2002 with a mark drawing code of 3000 and its transaction date is 78178639. The attorney assigned is Pamela S. Ratliff, attorney docket number 071279.0102. Since 31st of December 2009, the document can be found in the L20 law office in the publication and issue section. The status of this trademark was checked last on 01/31/2007.
Other trademarks by this attorney include , THE MAN IN THE HAT . The corresponded responsible for this trademark is Jerry W. Mills, located at BAKER BOTTS LLP, 2001 ROSS AVE STE 600, DALLAS TX 75201-2900.The state or country where the trademark was organized is by Proteom Limited. The legal entity type behing it is a Corporation, located at Babraham Hall, Babraham, zip CB2 4AT.
| GOODS AND/OR SERVICES | |
| International Class - 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. | |
|---|---|
| U.S. Class | 046 - Foods and Ingredients of Foods |
| Class Status | 6 - Active |
| Status Date | 11/07/2002 |
| Primary Code | 001 |
| International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
| U.S. Class | 052 - Detergents and Soaps |
| Class Status | 6 - Active |
| Status Date | 11/07/2002 |
| Primary Code | 005 |
| International Class - 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. | |
| U.S. Class | 038 - Prints and Publications |
| Class Status | 6 - Active |
| Status Date | 11/07/2002 |
| Primary Code | 009 |
| International Class - 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. | |
| U.S. Class | 101 - Advertising and Business |
| Class Status | 6 - Active |
| Status Date | 11/07/2002 |
| Primary Code | 042 |
| Goods codes | |
| GS0091 | computer hardware; data processors; computer software for use in the design or identification and characterization of genes and proteins through bioinformatics and related techniques; computer software for the design and identification of chemical entities for drug discovery research; computer software for use in gene therapy and disease diagnosis; computer software comprised of algorithms for use in analysis and data-mining of sequence chemical databases |
| D10000 | "PROTEOM" |
| GS0011 | chemicals for use in the manufacture of pharmaceuticals, cosmetics, and healthcare products; chemicals for use in science, namely, reagents for scientific research; chemicals for use in biotechnology and chemicals produced through biotechnological processes, namely, vaccines, therapeutic proteins and biologics; peptides and polypeptides and small molecules for use in scientific research; all of the aforesaid for use in assays, screens and diagnosis |
| GS0051 | pharmaceutical preparations for therapeutic, prophylactic and/or pharmacological purposes, namely, for use in relation to abdominal disease,abnormal substrate concentration, asthenia, atrophy, breast disease, cardiovascular disease, degeneration, dermatological disease, dystrophy, ear, nose, throat disease,endocrine disease, fatigue, gastro-intestinal disorder, genetic disorder,genitourinary disease, growth disorder, hematological disease, immune disorder,immunomodulation, infection, inflammation, injury, metabolic disorder, mouth disease, movement disorder, musculoskeletal disease, neoplasm, neurological,mental and cognitive disorder, nutritional disorder, ocular disease, pain,pregnancy disorder, prophylaxis, renal disease, respiratory disease, sleep disorder,somatosensory disorder, temperature disorder, toxicity and intoxication, ulcer,uterine motility; pharmaceutical preparations comprised of peptides and polypeptides for use in relation to abdominal disease, abnormal substrate concentration, asthenia, atrophy, breast disease, cardiovascular disease,degeneration, dermatological disease, dystrophy, ear, nose, throat disease,endocrine disease, fatigue, gastro-intestinal disorder, genetic disorder,genitourinary disease, growth disorder, hematological disease, immune disorder,immunomodulation, infection, inflammation, injury, metabolic disorder, mouth disease, movement disorder, musculoskeletal disease, neoplasm, neurological,mental and cognitive disorder, nutritional disorder, ocular disease, pain,pregnancy disorder, prophylaxis, renal disease, respiratory disease, sleep disorder,comatose disorder, temperature disorder, toxicity and intoxication, ulcer,uterine motility |
| GS0421 | providing temporary use of online non-downloadable computer software for use in the design or identification and characterization of genes and proteins through bioinformatics and related techniques; providing temporary use of online non-downloadable software for the design or identification of chemical entities for drug discovery research; computer software for use in gene therapy and disease diagnosis; providing temporary use of online non-downloadable computer software comprised of algorithms for use in analysis and data-mining of sequence and chemical databases; providing databases and online databases featuring complementary peptide sequences to all known genes in the human, bacterial,viral, animal and plant genomes; proteomic, genomic, bioinformatics, chemical and scientific consultation services, namely, providing advice and consultation in the fields of genomics, informatics, study of protein properties molecular design;medical, scientific and biotechnological research, namely, identification and characterization of genes and proteins and the design or identification of chemical entities through bioinformatics and related techniques, and providing consultancy and advisory services relating thereto; consultancy, advice and provision of information relating to drug discovery research, disease diagnosis; design,creation and provision of databases, namely, databases for the identification and characterization of genes, proteins and small molecules; design and creation of computer software for data-mining; design, creation and development of proprietary informatics technology, namely for the location and definition of peptide and small molecule ligands; use of bioinformatics and related techniques to design the core regions of molecular functionality and to enable the generation,design, development and validation of peptide and small molecule ligands for existing and novel targets; prediction and design of peptides from DNA sequence data; data-mining operations; scientific research, namely, identification of targets for therapeutic applications and design of chemical inhibitors, agonists and antagonists; design, optimization and development of chemical inhibitors,agonists and antagonists for specific targets for therapeutic applications; design,creation and provision of informatics based programs designed to monitor and research scientific databases and identify potential leads matched to a companydiscovery portfolio; genetic research services, namely, obtaining and analyzing genetic or chemical information; gene sequencing; laboratory research and collaboration with academic research groups in the field of drug discovery and healthcare research; pharmaceutical and biotechnical research, namely,collaboration with pharmaceutical and biotechnology companies; drug discovery and development programs; synthesis of peptides and small molecules |
DESIGN CODES:
- 26.09.02 - Plain single line squares; Squares, plain single line
- 26.17.10 - Lines, zig-zag; Zig-zag line(s)
- 27.03.01 - Geometric figures forming letters, numerals or punctuation
| PROSECUTION HISTORY | ||||
| Date | Description | Type | Code | |
|---|---|---|---|---|
| 03/25/2003 | NON-FINAL ACTION E-MAILED | F - First Action | GNRT - NON-FINAL ACTION E-MAILED | |
| 03/24/2003 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 02/01/2007 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | O - Outgoing Correspondence | MAB2 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | |
| 01/31/2007 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | O - Outgoing Correspondence | ABN2 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | |
| 06/29/2006 | INQUIRY TO SUSPENSION E-MAILED | S | GNSI - INQUIRY TO SUSPENSION E-MAILED | |
| 06/29/2006 | SUSPENSION INQUIRY WRITTEN | R - Renewal | CNSI - SUSPENSION INQUIRY - COMPLETED | |
| 12/21/2005 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | S | RCSC - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | |
| 05/23/2005 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | S | RCSC - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | |
| 11/22/2004 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | S | RCSC - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | |
| 05/01/2004 | LETTER OF SUSPENSION E-MAILED | S | GNSL - LETTER OF SUSPENSION E-MAILED | |
| 09/29/2003 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 10/30/2003 | CASE FILE IN TICRS | O - Outgoing Correspondence | CFIT - CASE FILE IN TICRS | |
| 09/29/2003 | PAPER RECEIVED | I - Incoming Correspondence | MAIL - PAPER RECEIVED | |
| 10/31/2002 | PAPER RECEIVED | I - Incoming Correspondence | MAIL - PAPER RECEIVED | |
The "PROTEOM" trademark, serial number 76561875 , was filed on 25th of November 2003 with a mark drawing code of 5000 and its transaction date is 76561875. The attorney assigned is Irwin Latner, attorney docket number . Since 31st of December 2009, the document can be found in the M60 law office in the publication and issue section. The employee responsible is SMITH, BRIDGETT G and the date it was published for opposition on 04/12/2005. The status of the trademark was checked last on 01/06/2006.
Other trademarks by this attorney include , THE MAN IN THE HAT . The corresponded responsible for this trademark is IRWIN LATNER, located at C/O SADIS & GOLDBERG LLC, 463 SEVENTH AVENUE, SUITE 1601, NEW YORK, NY 10018.The state or country where the trademark was organized is DE by Proteom Capital Management Ltd.. The legal entity type behing it is a Corporation, located at 15 East North Street, Dover, DE zip 19901.
| GOODS AND/OR SERVICES | |
| International Class - 036 - Insurance; financial affairs; monetary affairs; real estate affairs. | |
|---|---|
| U.S. Class | 102 - Insurance and Financial |
| Class Status | 6 - Active |
| Status Date | 12/17/2003 |
| Primary Code | 036 |
| Goods codes | |
| GS0361 | Investment advisory and management services to domestic and offshore clients and to private investment funds |
| PROSECUTION HISTORY | ||||
| Date | Description | Type | Code | |
|---|---|---|---|---|
| 03/06/2006 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | O - Outgoing Correspondence | MAB6 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | |
| 03/06/2006 | ABANDONMENT - NO USE STATEMENT FILED | S | ABN6 - ABANDONMENT - NO USE STATEMENT FILED | |
| 07/05/2005 | NOA MAILED - SOU REQUIRED FROM APPLICANT | O - Outgoing Correspondence | NOAM - NOTICE OF ALLOWANCE-MAILED | |
| 04/12/2005 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
| 03/23/2005 | NOTICE OF PUBLICATION | O - Outgoing Correspondence | NPUB - NOTICE OF PUBLICATION | |
| 01/12/2005 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
| 08/09/2004 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
| 07/29/2004 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
| 06/29/2004 | EXAMINER'S AMENDMENT ENTERED | I - Incoming Correspondence | XAEC - EXAMINER'S AMENDMENT ENTERED | |
| 06/30/2004 | EXAMINER'S AMENDMENT MAILED | F - First Action | CNEA - EXAMINER'S AMENDMENT MAILED | |
| 06/25/2004 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 12/17/2003 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM | |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.